UB Paderborn / Katalog / Suche / in CDI

The metabolic syndrome: a glance at its history

Journal of hypertension, 2006-04, Vol.24 (4), p.621-626

2006

Volltextzugriff (PDF)

Actions of Peroxisome Proliferator–Activated Receptors–γ Agonists Explaining a Possible Blood Pressure–Lowering Effect

American Journal of Hypertension, 2006-06, Vol.19 (6), p.646-653

2006

Volltextzugriff (PDF)

Antihypertensive therapy and the risk of new-onset diabetes

Diabetes care, 2006-05, Vol.29 (5), p.1167-1169

2006

Volltextzugriff (PDF)

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase

Journal of hypertension, 2004-09, Vol.22 (9), p.1769-1777

2004

Volltextzugriff (PDF)

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

American Journal of Hypertension, 2003-08, Vol.16 (8), p.689-697

2003

Volltextzugriff (PDF)

Level of kidney function determines cardiovascular fate after coronary bypass graft surgery

Circulation (New York, N.Y.), 2006-02, Vol.113 (8), p.1046-1047

2006

Volltextzugriff (PDF)

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension

American journal of hypertension, 2005-02, Vol.18 (2), p.227-234

2005

Volltextzugriff (PDF)

The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension : An open-label observational study

Metabolism, clinical and experimental, 2005-09, Vol.54 (9), p.1236-1242

2005

Volltextzugriff (PDF)

Do the Metabolic Effects of β Blockers Make Them Leading or Supporting Antihypertensive Agents in the Treatment of Hypertension?

The journal of clinical hypertension (Greenwich, Conn.), 2006-05, Vol.8 (5), p.351-356

2006

Volltextzugriff (PDF)

P1270INCREASED SCLEROSTIN, BUT NOT DKK-1 PROTEIN, IS ASSOCIATED WITH ELEVATED PULSE WAVE VELOCITY IN HEMODIALYSIS SUBJECTS

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P1252ASSOCIATIONS OF SERUM SCLEROSTIN AND DKK-1 PROTEIN WITH FUTURE CARDIOVASCULAR EVENTS AND MORTALITY IN HEMODIALYSIS PATIENTS; A PROSPECTIVE COHORT STUDY

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P1012NAIL CAPILLARY DENSITY DURING POSTOCCLUSIVE REACTIVE HYPEREMIA AND VENOUS CONGESTION IS MORE IMPAIRED IN DIABETIC COMPARED TO NON-DIABETIC CKD PATIENTS

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P1442CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED?

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P0156SHORT-TERM BLOOD PRESSURE VARIABILITY IN DIABETIC AND NON-DIABETIC PATIENTS WITH CKD STAGE 2, 3A, 3B AND 4

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P0763A COMPARATIVE STUDY OF ARTERIAL STIFFNESS AND WAVE REFLECTIONS IN DIABETIC AND NON-DIABETIC PATIENTS WITH CKD

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure

Journal of human hypertension, 2023-12, Vol.37 (12), p.1105-1111

2023

Volltextzugriff (PDF)

An Economic Evaluation of the 2003 European Society of Hypertension–European Society of Cardiology Guidelines for the Management of Mild-to-Moderate Hypertension in Greece

American journal of hypertension, 2005-09, Vol.18 (9), p.1233-1240

2005

Volltextzugriff (PDF)

Are β Blockers Passé for the Treatment of Hypertension?

The journal of clinical hypertension (Greenwich, Conn.), 2006-04, Vol.8 (4), p.239-240

2006

Volltextzugriff (PDF)

Cardiometabolic syndrome and chronic kidney disease: what is the link?

Journal of the cardiometabolic syndrome, 2006, Vol.1 (1), p.58

2006

Volltextzugriff (PDF)

P1287A COMPARATIVE STUDY OF BLOOD PRESSURE VARIABILITY INDICES BETWEEN PATIENTS UNDERGOING PERITONEAL DIALYSIS AND THOSE UNDER HEMODIALYSIS OR WITH CHRONIC KIDNEY DISEASE

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P0162HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS HAVE SEVERELY IMPAIRED ENDOTHELIAL POST-OCCLUSIVE FOREARM VASODILATORY RESPONSE ASSESSED WITH LASER SPECKLE CONTRAST IMAGING

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

P1294AMBULATORY BLOOD PRESSURE PROFILE IN PERITONEAL DIALYSIS COMPARED TO HEMODIALYSIS AND CHRONIC KIDNEY DISEASE PATIENTS

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm

International journal of cardiology, 2024-10, Vol.412, p.132339, Article 132339

2024

Volltextzugriff (PDF)

P-606: Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece

American journal of hypertension, 2005-05, Vol.18 (S4), p.228A-228A

2005

Volltextzugriff (PDF)

P-649: Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients

American journal of hypertension, 2005-05, Vol.18 (S4), p.244A-244A

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The metabolic syndrome: a glance at its history

Actions of Peroxisome Proliferator–Activated Receptors–γ Agonists Explaining a Possible Blood Pressure–Lowering Effect

Antihypertensive therapy and the risk of new-onset diabetes

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

Level of kidney function determines cardiovascular fate after coronary bypass graft surgery

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension

The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension : An open-label observational study

Do the Metabolic Effects of β Blockers Make Them Leading or Supporting Antihypertensive Agents in the Treatment of Hypertension?

P1270INCREASED SCLEROSTIN, BUT NOT DKK-1 PROTEIN, IS ASSOCIATED WITH ELEVATED PULSE WAVE VELOCITY IN HEMODIALYSIS SUBJECTS

P1252ASSOCIATIONS OF SERUM SCLEROSTIN AND DKK-1 PROTEIN WITH FUTURE CARDIOVASCULAR EVENTS AND MORTALITY IN HEMODIALYSIS PATIENTS; A PROSPECTIVE COHORT STUDY

P1012NAIL CAPILLARY DENSITY DURING POSTOCCLUSIVE REACTIVE HYPEREMIA AND VENOUS CONGESTION IS MORE IMPAIRED IN DIABETIC COMPARED TO NON-DIABETIC CKD PATIENTS

P1442CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED?

P0156SHORT-TERM BLOOD PRESSURE VARIABILITY IN DIABETIC AND NON-DIABETIC PATIENTS WITH CKD STAGE 2, 3A, 3B AND 4

P0763A COMPARATIVE STUDY OF ARTERIAL STIFFNESS AND WAVE REFLECTIONS IN DIABETIC AND NON-DIABETIC PATIENTS WITH CKD

Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure

An Economic Evaluation of the 2003 European Society of Hypertension–European Society of Cardiology Guidelines for the Management of Mild-to-Moderate Hypertension in Greece

Are β Blockers Passé for the Treatment of Hypertension?

Cardiometabolic syndrome and chronic kidney disease: what is the link?

P1287A COMPARATIVE STUDY OF BLOOD PRESSURE VARIABILITY INDICES BETWEEN PATIENTS UNDERGOING PERITONEAL DIALYSIS AND THOSE UNDER HEMODIALYSIS OR WITH CHRONIC KIDNEY DISEASE

P0162HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS HAVE SEVERELY IMPAIRED ENDOTHELIAL POST-OCCLUSIVE FOREARM VASODILATORY RESPONSE ASSESSED WITH LASER SPECKLE CONTRAST IMAGING

P1294AMBULATORY BLOOD PRESSURE PROFILE IN PERITONEAL DIALYSIS COMPARED TO HEMODIALYSIS AND CHRONIC KIDNEY DISEASE PATIENTS

Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm

P-606: Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece

P-649: Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients

Suchergebnisse filtern